Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Pharmacokinetics of Advagraf versus Prograf in Kidney Transplant Patients with Severe Diarrhoea
2009-014670-17Phase 4Completed
- Sponsor
- AZ Delta
- Start
- Nov 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in kidney allograft rejection (2 arms), sponsored by AZ Delta. Primary endpoints: Tacrolimus Co value (dose-corrected AUC 0–12 hours) and MPA Co value. Started Nov 2009; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2009-014670-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014670-17.